Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-19-014449
Filing Date
2019-08-07
Accepted
2019-08-07 13:58:01
Documents
40
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 6-K form6k.htm 6-K 15491
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 1029782
3 EXHIBIT 99.2 ex99_2.htm EX-99.2 410949
10 image00002.jpg GRAPHIC 2910
  Complete submission text file 0001140361-19-014449.txt   4036474

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT gmda-20190630.xml EX-101.INS 672457
5 XBRL TAXONOMY EXTENSION SCHEMA gmda-20190630.xsd EX-101.SCH 31590
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gmda-20190630_cal.xml EX-101.CAL 41805
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gmda-20190630_def.xml EX-101.DEF 108449
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE gmda-20190630_lab.xml EX-101.LAB 395723
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gmda-20190630_pre.xml EX-101.PRE 214518
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38716 | Film No.: 191004874
SIC: 2836 Biological Products, (No Diagnostic Substances)